Could a common MS drug also fight debilitating fatigue?
NCT ID NCT05319093
Summary
This study aimed to see if starting the multiple sclerosis (MS) medication ozanimod could reduce the severe fatigue many patients experience. Researchers observed 26 adults with MS for three months, using smartphone apps and activity trackers to measure fatigue, mood, and sleep. They also used brain scans to try to understand which patients might benefit most from the treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Brigham and Women's Hospital
Boston, Massachusetts, 02115, United States
Conditions
Explore the condition pages connected to this study.